Claudins and mineral metabolism.
Hou J.
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):308-13. doi: 10.1097/MNH.0000000000000239.
Magnesium metabolism in childhood.
Geven WB, Monnens LA, Willems JL.
Miner Electrolyte Metab. 1993;19(4-5):308-13.
Mechanisms and causes of hypomagnesemia.
Agus ZS.
Curr Opin Nephrol Hypertens. 2016 Jul;25(4):301-7. doi: 10.1097/MNH.0000000000000238.
Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
Cimbek EA, Şen Y, Yuca SA, Peru H.
J Pediatr Endocrinol Metab. 2015 May;28(5-6):713-6. doi: 10.1515/jpem-2013-0254.
Primary familial hypomagnesemia syndrome: a new approach in treatment.
Nesibe A, Sinasi O.
J Pediatr Endocrinol Metab. 2012;25(5-6):599-602.
Familial primary hypomagnesemia complicated with brain atrophy and cardiomyopathy.
Shu SG, Mak SC, Chen YC, Chi CS.
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1997 Jul-Aug;38(4):293-6.
Genetic causes of hypomagnesemia, a clinical overview.
Viering DHHM, de Baaij JHF, Walsh SB, Kleta R, Bockenhauer D.
Pediatr Nephrol. 2017 Jul;32(7):1123-1135. doi: 10.1007/s00467-016-3416-3. Epub 2016 May 27.
[Familial hypomagnesaemia with hypercalciuria and nephrocalcinosis. Its history].
García-Nieto VM, Claverie-Martín F, Loris-Pablo C.
Nefrologia. 2014;34(1):5-10. doi: 10.3265/Nefrologia.pre2013.Nov.12230.
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis: phenotype-genotype correlation and outcome in 32 patients with CLDN16 or CLDN19 mutations.
Godron A, Harambat J, Boccio V, Mensire A, May A, Rigothier C, Couzi L, Barrou B, Godin M, Chauveau D, Faguer S, Vallet M, Cochat P, Eckart P, Guest G, Guigonis V, Houillier P, Blanchard A, Jeunemaitre X, Vargas-Poussou R.
Clin J Am Soc Nephrol. 2012 May;7(5):801-9. doi: 10.2215/CJN.12841211. Epub 2012 Mar 15.
The emerging roles and therapeutic potential of cyclin M/CorC family of Mg(2+) transporters.
Funato Y, Miki H.
J Pharmacol Sci. 2022 Jan;148(1):14-18. doi: 10.1016/j.jphs.2021.09.004. Epub 2021 Sep 20.
